Skip to main content
. 2022 Oct 24;7(3):125–145. doi: 10.1159/000526318

Fig. 3.

Fig. 3

Clustered ranking plots for the relative ranking of treatment for the efficacy of PDA closure and composite risk outcomes in network meta-analysis. a For all studies, b For GA <28 weeks, c For GA ≥28 weeks. Clustered ranking plots for the medical treatments of PDA based on the SUCRA. The larger the SUCRA, the higher the rate of PDA closure, and the lower the rate of adverse effects.